Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2000

View Archived Issues

Elan outlines significant Q2 developments

5-HT1A antagonist WAY-100635 reduces cognitive impairment in marmosets

AY-9944 may provide enhanced resistance to HIV infection

HIV-Tat conjugate system as a potential AIDS vaccine

Antiinflammatory profile of ridogrel examined in inflamed colorectal mucosal biopsies

5-HT2C antagonists potentiate the effects of dopaminergic drugs in PD

Sordarin derivatives active against C. immitis in vivo

Identification of gene implicated in PPH may lead to new treatments for devastating disease

Protegrin IB-367 progresses through clinical development for the palliation of mucositis

Salix's Colazal approved in U.S. for ulcerative colitis

ABX-EGF will be codeveloped by Abgenix and Immunex

Dura seeks partners for new Spiros S2 delivery technology; refocuses strategy

Micrologix proceeds to next phase of clinical development with MBI-853NL

Interactions between alcohol and rupatadine examined in humans

WinRho SDF approved in Australia, CSL to distribute the product

Schein licenses ML Laboratories' Clickhaler in Canada

Beneficial effects of 4-AP in relapsing-remitting multiple sclerosis

CIMA licenses DuraSolv dosage form to Schwarz

Synergism reported by Aventis for combination chemotherapies

Abbot's divalproex newly formulated for once-daily dosing

Topically applied GAG synthesis inhibitors useful for corneal haze

Preparation, activity and use of ICE inhibitors disclosed by Warner-Lambert (Pfizer)

Fujisawa presents new benzimidazoles active as bradykinin antagonists

New androgen receptor modulators useful as anabolic agents

Specific inhibitors of COX-2 reported by Ortho-McNeil

Tularik advances anticancer agents in Q2 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...